New York, NYNCT06941467Now EnrollingIRB Ready

Wound Healing Clinical Trial in New York, NY

Access cutting-edge wound healing treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Icahn School of Medicine at Mount Sinai

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access wound healing specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related wound healing treatment provided free

Apply for This New York Location

Check if you qualify for this wound healing clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Wound Healing Study in New York

Topical timolol, a β2-Adrenergic receptor (B2AR) antagonist, has demonstrated promise in wound healing over the past several years. The majority of the literature has evaluated the use of topical timolol to shorten wound healing time in chronic wounds of non-surgical etiologies. To date, there are no prospective randomized clinical trials evaluating the role of topical timolol for shortening wound healing time in acute open surgical wounds. Therefore, the purpose of this study is to determine whether or not topical timolol solution decreases time to wound healing in patients with defects after Mohs Micrographic Surgery (MMS) that cannot be closed with sutures and are left to heal by second intent. The research team also will look to determine if there is a difference in cosmesis of wounds treated with topical timolol compared to those treated with the standard of care. The present study will primarily focus on wounds in the distal lower extremity as these are most commonly left to heal by secondary intent

Sponsor: Icahn School of Medicine at Mount Sinai

Who Can Participate

Inclusion Criteria

Be scheduled to undergo MMS at 234 East 85th St for a skin cancer that is deemed Mohs
Appropriate by the Mohs surgery appropriate use criteria
Have an open surgical wound \< 4 cm and \> 0.5 cm
Be ≥18 years of age
English-speaking
Provide a signed and dated informed consent form
State willingness to comply with all study procedures

Exclusion Criteria

Age less than 18 years of age
Open surgical wound \> 4 cm
If tumor clearance cannot be achieved with MMS
Pregnant women
Breastfeeding women
Patients who are taking oral beta-blockers (ie oral timolol, metoprolol, carvedilol, propranolol, atenolol)
Patients who are currently taking any of the following medications: clonidine, digoxin, methyldopa, quinidine, fluoxetine and paroxetine, bupropion
Patient currently taking a calcium channel blocker AND has pre-existing heart failure as defined by a reduced ejection fraction
Patients with pre-existing hypotension
Pre-existing diagnosis of sinus bradycardia
Pre-existing diagnosis of second or third degree atrioventricular block
Congestive heart failure
Pre-existing diagnosis of severe asthma
Pre-existing diagnosis of chronic obstructive pulmonary disease
Any known hypersensitivity to 0.5% timolol solution
Patients who have a wound where primary closure is feasible and desired by the patient
Defect size \<0.5 cm
Prior sensitivity or known allergy to timolol

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT06941467) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Wound Healing Treatment Options in New York, NY

If you're searching for wound healing treatment options in New York, NY, this clinical trial (NCT06941467) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced wound healing specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all wound healing clinical trials near you to find additional studies recruiting in your area.

More Wound Healing Trials in New York, NY

See all wound healing clinical trials recruiting in New York — not just this study.

Browse Wound Healing Trials in New York

Browse More Trials by Condition

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY